Beamtree is pleased to report strong results for the half-year ending 31 December 2024 (1H FY25), continuing our growth trajectory with revenue growth driven by international markets and customer renewals.
Beamtree supports sustainable, high-quality healthcare in Australia, New Zealand, and over 25 countries globally with AI-powered decision support and data solutions. We saw notable expansion in key markets, including the UK, Canada, and Saudi Arabia, while strengthening partnerships with global health technology leaders.
Key Highlights:
- Double-digit revenue growth continued in 1H FY25, driven by international expansion and strong customer retention.
- Sales pipeline matured to $61 million, a 50% increase in the last 12 months.
- Operating cashflow broke even, compared to a $2.3 million cash outflow in the same period last year.
- Significant progress on product innovation and market penetration, including the launch of the Integrated Coding Platform in Saudi Arabia and new autonomous coding solutions with initial agreements in Australia, Canada, and the UK.
We remain confident in achieving a $60 million ARR target by the end of 2026, with continued revenue growth, and product expansion.
CEO Tim Kelsey commented: “These results reflect the strength of our international growth strategy and our team’s commitment to delivering innovative solutions that improve healthcare efficiency and patient outcomes globally.”
Share this article
